PAA 2.78% 18.5¢ pharmaust limited

Ann: Clinical Trial in Dogs is now open for accrual, page-9

  1. 291 Posts.
    lightbulb Created with Sketch. 10
    Agreed. PAA is much further advanced with the two studies, with initial challenges overcome. Yet the share price is much lower! A strange market, indeed!
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.